Advantages of the use of telemedicine in oncology patients from the medical and patient perspectives

Authors

Keywords:

TELEMEDICINE, ONCOLOGY, CANCER.

Abstract

Introduction: telemedicine, driven by the COVID-19 pandemic, has become an essential component of global healthcare offering improved access and quality of care, especially for oncology patients.

Objective: to identify the advantages of the use of telemedicine in oncology patients from a medical and patient perspective.

Methods: a systematic review was carried out in the following databases: PubMed, ClinicalKey, Scopus, Scielo and Google Scholar. Articles published from January 2019 to March 2024 were selected, and the search strategy included the keywords “telemedicine”, “oncology”, “cancer” and their English equivalents.

Development: the main advantages found from the perspective of oncology patients with respect to telemedicine are that it helps them to overcome geographical limits and contributes to a better quality and better accessibility of medical care; in addition, it is beneficial to them as a strategy for the prevention of infections originated by the immunosuppression to which they are exposed. From the medical perspective, the advantages mentioned are that it has become a useful tool in the follow-up and control of treatments and symptoms of oncology patients, it helps to offer greater coverage in terms of the number of treatments and all this without altering the doctor-patient relationship.

Conclusions: telemedicine is a tool that offers significant benefits for both oncology patients and their oncology physicians.

 

Downloads

Download data is not yet available.

Author Biographies

Andrea Stefany Cerrón Medina, Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Investigadora del Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Nicolás Bernardo Cárdenas Flores, Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Investigador del Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Paola Nicole Hinostroza Camarena, Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Investigadora del Instituto de Investigación de Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima-Perú

Brady Ernesto Beltran Garate, Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

Médico cirujano, especialista en Oncología Médica, Magíster en Oncología Molecular. Investigador Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

Joyce Desposorio Robles, Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

Médico cirujano, especialista en Gestión de Servicios de Salud, Magister Gerencia en Servicios de Salud. Investigador Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

José Manuel Vela Ruiz, Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

Médico cirujano, especialista en Oncología Médica, Magíster en Gerencia de servicios de Salud. Investigador Instituto de investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima - Perú

References

1. Gondal H, Abbas T, Choquette H, Le D, Chalchal HI, Iqbal N, et al. Patient and Physician Satisfaction with Telemedicine in Cancer Care in Saskatchewan: A Cross-Sectional Study. Curr Oncol [Internet]. 2022 [citado 07/04/2024]]; 29(6):3870-80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221857/

2. Zaporta Ramos JA, Ramos Campi YC, Barba Maggi MA, De La Calle Andrade LJ. Telemedicina. ¿De qué manera impacta en práctica oncológica cotidiana? J Sci Res Rev Cienc E Investig [Internet]. 2022 [citado 27/04/2024]]; 7(3): 61-76. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8695667

3. Contreras M. Telemedicina: ¿Puede reemplazar la consulta no presencial la visita al médico? [Internet]. La Tercera; 2021 [citado 27/04/2024]]. Disponible en: https://www.latercera.com/laboratoriodecontenidos/noticia/expertos-aseguran-que-la-telemedicina-se-mantendra-pospandemia-es-el-futuro/KRKHGYUD7ZDI5GP3EYRWVNWXAE/#

4. Ministerio de Salud. Dirección General de Telesalud, Referencia y Urgencias. Reglamento de la Ley N° 30421, Ley Marco De Telesalud, y del Decreto Legislativo No 1490, Decreto Legislativo que fortalece los alcances de la Telesalud [Internet]. Lima-Perú; 2021 [citado 08/04/2024]. Disponible en: https://bvs.minsa.gob.pe/local/MINSA/5418.pdf

5. Gob.pe. ¿Qué es Telesalud? Servicios de telemedicina [Internet]. Gob.; 2024 [citado 27/04/2024]]. Disponible en: https://www.gob.pe/11729-que-es-telesalud-servicios-de-telemedicina

6. Chang PJ, Jay GM, Kalpakjian C, Andrews C, Smith S. Patient and Provider‐Reported Satisfaction of Cancer Rehabilitation Telemedicine Visits During the COVID‐19 Pandemic. PM R [Internet]. 2021 [citado 07/04/2024]]; 13(12): 1362-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013293/

7. Miziara RA, Maesaka JY, Matsumoto DRM, Penteado L, Anacleto AADS, Accorsi TAD, et al. Teleoncology Orientation of Low-Income Breast Cancer Patients during the COVID-19 Pandemic: Feasibility and Patient Satisfaction. Rev Bras Ginecol Obstet [Internet]. 2021 [citado 27/04/2024]]; 43(11): 840-6. Disponible en: https://www.scielo.br/j/rbgo/a/HKWbw4VzYyYdXPhLvdQfqFg/?format=pdf

8. Aguilar-Ramos P, Gonzales-Medina C, Gutarra-Vilchez R, Aguilar-Ramos P, Gonzales-Medina C, Gutarra-Vilchez R. Calidad de atención y satisfacción de usuarias atendidas por teleconsulta en Ginecología Oncológica del Hospital Nacional Edgardo Rebagliati Martins de EsSalud, agosto a octubre del 2021. Horiz Med [Internet]. 2022 [citado 27/04/2024]]; 22(3): e1960. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1727-558X2022000300009

9. Murcia-Monroy EM, Lineros-Hurtado JA, Aguilera-Lopez J. Respuesta en la atención del cáncer durante la pandemia por COVID-19 en Colombia: gestión en clínicas y hospitales. MedUNAB [Internet]. 2022 [citado 07/04/2024]]; 25(3): 385-96. Disponible en: https://revistas.unab.edu.co/index.php/medunab/article/view/4204/3710

10. Ministerio de Salud. Resolución Ministerial N° 658-2019/minsa. Prioridades Nacionales de Investigación en Salud en Perú 2019-2023 [Internet]. Lima-Perú; 2019 [citado 27/04/2024]]. Disponible en: https://cdn.www.gob.pe/uploads/document/file/343478/Resoluci%C3%B3n_Ministerial_N__658-2019-MINSA.PDF?v=1563814986

11. Universidad Ricardo Palma. Líneas de Investigación 2021-2025 [Internet]. Lima-Perú; 2021 [citado 27/04/2024]]. Disponible en: https://www.urp.edu.pe/pdf/id/50606/n/lineas-de-investigacion-urp-periodo-2021-2025-acu-0510-2021.pdf

12. Shaverdian N, Gillespie EF, Cha E, Kim SY, Benvengo S, Chino F, et al. Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology. J Natl Compr Canc Netw [Internet]. 2021 [citado 27/04/2024]]; 19(10): 1174-80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254817/

13. Viteri Malone MA, Cabrera Chien L, Pergolotti M, Canin B, Battisti NML, Krok-Schoen JL, et al. Evolving oncology care for older adults: Trends in telemedicine use after one year of caring for older adults with cancer during COVID-19. J Geriatr Oncol [Internet]. 2023 [citado 27/04/2024];14(6): 101497. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264234/

14. Margolin EJ, Pina Martina LA, Miles CH, Wenske S, McKiernan JM, DeCastro GJ, et al. Telemedicine in management of genitourinary malignancies: Patient and physician perspectives. Urol Oncol Semin Orig Investig [Internet]. 2021 [citado 28/04/2024]; 39(8): 480-6. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1078143921001599?via%3Dihub

15. Wong J, Gonzalez R, Albright B, Hayes T, Swartz A, Havrilesky LJ, et al. Telemedicine and gynecologic oncology: caring for patients remotely during a global pandemic. AJOG Glob Rep [Internet]. 2022 [citado 28/04/2024]; 2(4): 100124. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703802/

16. Janke MJ, Aaron B, McLaughlin HD, Liu Y, Uppal S. Patient perspective on virtual prechemotherapy visits in gynecologic oncology. Gynecol Oncol Rep [Internet]. 2024 [citado 10/05/2024]; 53:101397. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11061257/

17. Maroongroge S, De B, Woodhouse KD, Bassett RL Jr, Lee P, Bloom ES, et al. Physician Perspectives on Telemedicine in Radiation Oncology. Adv Radiat Oncol [Internet]. 2023 [citado 10/05/2024]; 8(2): 101005. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598490/

18. Suc L, Daguenet E, Louati S, Gras M, Langrand-Escure J, Sotton S, et al. La téléconsultation pour le suivi après radiothérapie du cancer de la prostate : une place à l’innovation numérique en cancérologie. Cancer/Radiothérapie [Internet]. 2021 [citado 10/05/2024]; 25(1): 45-50. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1278321820303413

19. Nestlerode C, Pavelka J, Basil J, Schuler K, Fellner AN, Ghaderian M, et al. Patient perspectives of telemedicine in gynecologic oncology during COVID. Gynecol Oncol Rep [Internet]. 2022 [citado 10/05/2024]; 43:101071. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514970/

20. Frydman JL, Berkalieva A, Liu B, Scarborough BM, Mazumdar M, Smith CB. Telemedicine utilization in the ambulatory palliative care setting: Are there disparities? J Pain Symptom Manage [Internet]. 2022 [citado 10/05/2024]; 63(3): 423-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854351/

21. Pinto C da S, Borsatto AZ, Vaz DC, Sampaio SG dos SM, Oliveira LC de. Telemedicina en Cuidados Paliativos Oncológicos: un Legado de la Pandemia. Rev Bras Cancerol [Internet]. 2023 [citado 19/05/2024]; 69(1): e-142698. Disponible en: https://rbc.inca.gov.br/index.php/revista/article/view/2698/2861

22. López-Fernández A, Villacampa G, Grau E, Salinas M, Darder E, Carrasco E, et al. Patients’ and professionals’ perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic. Genet Med [Internet]. 2021 [citado 26/05/2024]; 23(8):1450-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023774/

23. Barriga-Chambi F, Ccami-Bernal F, Alarcon-Casazuela AL, Copa-Uscamayta J, Yauri-Mamani J, Oporto-Arenas B, et al. Satisfacción del personal de salud y pacientes sobre un servicio de telesalud de un hospital de Perú. Rev Peru Med Exp Salud Publica [Internet]. 2022 [citado 28/04/2024]; 39(4): 415-24. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342022000400415

24. Montenegro P, Pinillos L, Young F, Aguilar A, Tirado-Hurtado I, Pinto JA, et al. Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic. Crit Rev Oncol Hematol [Internet]. 2021 [citado 19/05/2024];157:103129. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581359/

25. Schuster-Bruce AT, Middleton HAR, Macpherson C, Pearce BCS, Evans A. Patient satisfaction with nurse-led end of treatment telephone consultation for breast cancer during COVID-19 pandemic. Breast J [Internet]. 2021 [citado 26/06/2024]; 27(1):77-9. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/tbj.14034

26. Kwan Chung CK, Riquelme Benítez R. Telemedicina desde la perspectiva del personal de salud en un hospital público en Paraguay, 2023. Int J Med Surg Sci [Internet]. 2024 [citado 26/06/2024];1-9. Disponible en: https://revistas.uautonoma.cl/index.php/ijmss/article/view/2421/1723

27. Dwyer ER, Holt SK, Wolff EM, Stewart B, Katz R, Reynolds J, et al. Patient-centered outcomes of telehealth for the care of rural-residing patients with urologic cancer. Cancer [Internet]. 2023 [citado 26/06/2024];129(18):2887-92. Disponible en: https://doi.org/10.1002/cncr.34848

28. Sathiyaraj A, Lopez H, Surapaneni R. Patient satisfaction with telemedicine for prechemotherapy evaluation during the COVID-19 pandemic. Future Oncol [Internet]. 2021 [citado 26/06/2024];17(13):1593-600. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909235/

29. Cascella M, Coluccia S, Grizzuti M, Romano MC, Esposito G, Crispo A, et al. Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study. Curr Oncol [Internet]. 2022 [citado 26/06/2024];29(8):5566-78. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406413/

30. Mojdehbakhsh RP, Mora Hurtado AC, Uppal S, Milakovich H, Spencer RJ. The long game: Telemedicine patient satisfaction metrics and methods of recurrence detection for gynecologic cancer patients throughout the initial year of the COVID-19 pandemic. Gynecol Oncol Rep [Internet]. 2022 [citado 26/06/2024];42:101037. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287468/

Published

2024-12-12

How to Cite

1.
Cerrón Medina AS, Cárdenas Flores NB, Hinostroza Camarena PN, Beltran Garate BE, Desposorio Robles J, Vela Ruiz JM. Advantages of the use of telemedicine in oncology patients from the medical and patient perspectives. Rev Ciencias Médicas [Internet]. 2024 Dec. 12 [cited 2026 Feb. 13];28(1):e6458. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6458

Issue

Section

REVIEW ARTICLES